DOI:10.2214/AJR.07.3573
AJR 2008; 191:589-597
© American Roentgen Ray Society
Craniofacial and Intracranial Manifestations of Langerhans Cell Histiocytosis: Report of Findings in 100 Patients
Nicholas D'Ambrosio1,2,
Stephanie Soohoo1,
Craig Warshall1,
Alan Johnson1 and
Sasan Karimi2
1 Department of Radiology, Schneider Children's Hospital, Long Island Jewish
Medical Center, New Hyde Park, NY 11040.
2 Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York
Ave., New York, NY 10065.
Received December 22, 2007;
accepted after revision February 4, 2008.
Address correspondence to N. D'Ambrosio
(dambrosn{at}hotmail.com).
Abstract
OBJECTIVE. The purpose of this study was to review the craniofacial
and intracranial clinical and radiologic manifestations of patients diagnosed
with Langerhans cell histiocytosis (LCH). This report will compare the
frequency of the various manifestations found in our series with those
reported in the medical literature.
CONCLUSION. In LCH, involvement of the calvaria, skull base,
maxillofacial bones, and hypothalamic–pituitary axis is fairly common.
The precise location of these lesions contributes to the variety of clinical
manifestations of LCH, which includes scalp and/or facial swelling, seizures,
hearing loss, recurrent otitis media, gingival bleeding, proptosis, diabetes
insipidus, and cranial nerve palsies.
Keywords: craniofacial intracranial Langerhans cell histiocytosis
Introduction
Langerhans cell histiocytosis (LCH) is a rare disease of unknown cause.
LCH, formerly known as histiocytosis X, is a disease entity composed of three
rare proliferative disorders of bone marrow–derived antigen-presenting
cells of the dendritic cell line, also known as Langerhans cells
[1]. LCH is composed of three
distinct clinical syndromes that show indistinguishable histology.
Characteristically, these lesions stain positively with histochemical stains,
S-100 and CD1a. Eosinophilic granuloma is limited to bone in patients usually
5–15 years old. Hand-Schüller-Christian disease is characterized by
multifocal bone lesions and extraskeletal involvement of the
reticuloendothelial system (RES) and pituitary gland, usually seen in children
1–5 years old. In Letterer-Siwe disease, there is disseminated
involvement of the RES with a fulminant clinical course in children less than
2 years old [2,
3].
LCH is a rare disease, with a reported incidence of 0.2–2.0 cases per
100,000 children under 15 years old
[4]. LCH is usually a
self-limited disease, with a varied clinical and radiologic presentation. The
prognosis is generally poor in children with organ dysfunction. In the absence
of organ dysfunction, children with either localized or multifocal LCH have an
excellent prognosis [5]. The
clinical and radiologic presentations of LCH are variable and range from a
lytic skeletal lesion incidentally seen at radiography to widespread disease
with severe organ dysfunction
[5].
Materials and Methods
Between 1997 and 2007, 100 patients with biopsy-proven LCH were treated in
the oncology unit at Schneider Children's Hospital at Long Island Jewish
Medical Center. A retrospective review of radiographic images and reports was
performed. There were 48 male patients and 52 female patients ranging in age
from 4 months to 24 years. The average age at presentation was 4 years. All
patients underwent imaging studies, mostly skeletal surveys and CT.
Thirty-seven of 100 patients underwent MRI of the brain during their course of
treatment.
Results
Calvaria
Ninety-six percent of the patients in this series had bone involvement.
Those patients without bone involvement had varying clinical manifestations,
such as pulmonary disease, lymphadenopathy, and visceral organ and skin
lesions. Fifty-eight of 96 patients (60%) had a solitary bone abnormality, and
38 patients (40%) had multiple lesions. By far, the most common bone involved
in the series was the skull, affecting 52 of 96 patients (54%). In particular,
the calvarium was affected in 45% of patients. Of the patients with calvarial
involvement, the parietal bone was most commonly affected, in approximately
half of the patients. Patients with skull involvement may be asymptomatic or
have a palpable soft-tissue mass. The lesions are round or oval lytic lesions,
involve the full thickness of the calvarium, have circumscribed margins, and
have characteristic beveled edges
[6]. The beveled edge
represents the unequal destruction of the outer and inner tables of the skull
(Figs. 1A and
1B). A bone sequestrum is
highly characteristic. The classic button sequestrum is a radiolucent lesion
surrounding a central bone opacity and may be found in other disease
processes, such as osteomyelitis
[7]. On MRI, the calvarial
lesions are isointense to gray matter on T1, isointense or hyperintense on T2,
and show variable enhancement after gadolinium ad ministration (Figs.
2A,
2B, and
2C).

View larger version (64K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B —Two different 4-year-old girls with multiple palpable scalp
abnormalities. Axial CT of different patient from A shows unequal
destruction of outer table (arrowhead) and inner table
(arrow), which produces beveled-edge appearance.
|
|

View larger version (111K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2A —3-year-old girl with palpable scalp soft-tissue mass. Axial
MR images of brain show well-circumscribed calvarial lesion (arrows),
which is isointense on T1 (A), enhances almost homogeneously after
gadolinium administration (B), and is hyperintense on T2 (C).
Arrowhead in C denotes dense sclerotic central focus, which corresponds
to button sequestrum found on CT scan (not shown). Note generalized brain
atrophy, which is associated finding in Langerhans cell histiocytosis.
|
|

View larger version (114K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2B —3-year-old girl with palpable scalp soft-tissue mass. Axial
MR images of brain show well-circumscribed calvarial lesion (arrows),
which is isointense on T1 (A), enhances almost homogeneously after
gadolinium administration (B), and is hyperintense on T2 (C).
Arrowhead in C denotes dense sclerotic central focus, which corresponds
to button sequestrum found on CT scan (not shown). Note generalized brain
atrophy, which is associated finding in Langerhans cell histiocytosis.
|
|

View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2C —3-year-old girl with palpable scalp soft-tissue mass. Axial
MR images of brain show well-circumscribed calvarial lesion (arrows),
which is isointense on T1 (A), enhances almost homogeneously after
gadolinium administration (B), and is hyperintense on T2 (C).
Arrowhead in C denotes dense sclerotic central focus, which corresponds
to button sequestrum found on CT scan (not shown). Note generalized brain
atrophy, which is associated finding in Langerhans cell histiocytosis.
|
|
Skull Base
Of the 52 LCH patients with skull involvement in our series, the skull
base, in particular, was affected in 27 patients (52%). The temporal bone was
most commonly involved, affecting 13 patients, accounting for 48% of patients
with skull base involvement and 13% of the entire series of 100 patients
diagnosed with LCH. Two patients had bilateral mastoid involvement.
Eosinophilic granuloma of the temporal bone has been described, beginning
with the earliest reports of the disease
[8]. The radiologic findings of
temporal bone involvement typically show destructive, lytic "punched
out" bone lesions involving the mastoids, with the squamous portion and
middle ear less affected [9]
(Figs. 3A and
3B). CT is the preferred
imaging technique for describing the extent of temporal bone involvement and
has a role in monitoring disease activity and response to treatment.

View larger version (67K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3A —2-year-old boy with recurrent otitis media and aural
discharge. Axial CT bone (A) and soft-tissue (B) window images
show extensive punched out, lytic lesion with associated soft-tissue mass
involving right sphenoid bone, extending into middle cranial fossa
(arrows).
|
|

View larger version (83K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3B —2-year-old boy with recurrent otitis media and aural
discharge. Axial CT bone (A) and soft-tissue (B) window images
show extensive punched out, lytic lesion with associated soft-tissue mass
involving right sphenoid bone, extending into middle cranial fossa
(arrows).
|
|
Some patients have an associated soft-tissue mass, which enhances
homogeneously on CT and MRI after contrast administration. On MRI, the
soft-tissue mass is hyperintense on T2, with variable signal intensity on T1
(hypointense to isointense)
[10] (Figs.
4A and
4B).

View larger version (109K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4A —4-year-old girl with right ear pain and discharge. Axial
T1-weighted MR image (A) shows isointense lesion in right temporal bone
(arrow), which enhances after gadolinium administration (B).
At biopsy, this lesion was proven to be Langerhans cell histiocytosis.
|
|

View larger version (108K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4B —4-year-old girl with right ear pain and discharge. Axial
T1-weighted MR image (A) shows isointense lesion in right temporal bone
(arrow), which enhances after gadolinium administration (B).
At biopsy, this lesion was proven to be Langerhans cell histiocytosis.
|
|
One of the patients in our series presented with an isolated abducens
sixth-nerve palsy. CT showed extension of disease from the mastoids to the
petrous apex, Dorello's canal, and cavernous sinus, which has rarely been
reported in the literature (Figs.
5A,
5B,
5C, and
5D). Those few reported cases
with involvement of the cavernous sinus and petrous apex also involved the
clivus, which was not involved in this particular case
[11]. However, two patients in
the series of 100 patients had lesions involving the clivus.

View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5D —16-year-old boy who presented with left-sided sixth-nerve
palsy. Histologic specimen from mastoid biopsy shows Langerhans cells
(arrows), which stain positively for S-100 and CD1a. Top image = H
and E, x600. Bottom images are immunohistochemical stains with a brown
chromogen. (Courtesy of Dr. Morris Edelman, New Hyde Park, NY)
|
|
Finally, the jugular foramen was involved in 2% of our series of patients.
LCH involvement of the jugular foramen is very rare. One of the two patients
was a 2-year-old boy who presented clinically with hoarseness and difficulty
swallowing (Figs. 6A,
6B,
6C,
6D,
6E, and
6F). CT of the head and neck
revealed a large, lytic lesion centered within the right occipital bone,
involving the jugular foramen.

View larger version (83K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6A —2-year-old boy who presented with hoarseness and difficulty
swallowing. Axial CT bone (A) and soft-tissue (B) window images
show large, lytic lesion centered in right occipital bone, involving jugular
foramen (arrows).
|
|

View larger version (95K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6B —2-year-old boy who presented with hoarseness and difficulty
swallowing. Axial CT bone (A) and soft-tissue (B) window images
show large, lytic lesion centered in right occipital bone, involving jugular
foramen (arrows).
|
|

View larger version (95K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6C —2-year-old boy who presented with hoarseness and difficulty
swallowing. Axial T1-weighted MR images without (C) and with (D)
gadolinium enhancement of skull base show large isointense jugular foramen
lesion (arrows), which enhances avidly after gadolinium
administration.
|
|

View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6D —2-year-old boy who presented with hoarseness and difficulty
swallowing. Axial T1-weighted MR images without (C) and with (D)
gadolinium enhancement of skull base show large isointense jugular foramen
lesion (arrows), which enhances avidly after gadolinium
administration.
|
|

View larger version (113K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6E —2-year-old boy who presented with hoarseness and difficulty
swallowing. Coronal T1-weighted MR images without (E) and with
(F) gadolinium enhancement of skull base show large isointense jugular
foramen lesion (arrows), which enhances avidly after gadolinium
administration.
|
|

View larger version (116K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6F —2-year-old boy who presented with hoarseness and difficulty
swallowing. Coronal T1-weighted MR images without (E) and with
(F) gadolinium enhancement of skull base show large isointense jugular
foramen lesion (arrows), which enhances avidly after gadolinium
administration.
|
|
Craniofacial
Facial swelling is a common clinical problem in the pediatric population.
Khanna et al. [12] classified
pediatric facial swelling into the following four groups: acute swelling with
inflammation, nonprogressive swelling, slowly progressive swelling, and
rapidly progressive swelling. LCH typically presents as rapidly progressive
facial swelling.
Distinguishing an aggressive process such as LCH from a more benign process
such as osteomyelitis can sometimes be difficult. Both may present with
rapidly progressive facial swelling. For example, an 8-year-old boy in our
series presented with rapidly progressing frontal swelling, with associated
skin induration. Without any history of trauma, the presumptive clinical
diagnosis was frontal sinusitis with an associated subgaleal abscess, or
Pott's puffy tumor. However, CT was performed, which showed an aggressive,
lytic punched out lesion arising from the frontal sinus, with an associated
large soft-tissue mass. Subsequent MRI revealed extension of this process into
the epidural space. Biopsy revealed LCH (Figs.
7A,
7B,
7C, and
7D).

View larger version (64K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7A —8-year-old boy with rapidly progressive frontal swelling.
Lateral skull radiograph windowed to accentuate soft tissues shows prominent
soft-tissue swelling in frontal region (arrowhead). Note underlying
frontal bone with eroded cortices.
|
|

View larger version (87K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7B —8-year-old boy with rapidly progressive frontal swelling.
Axial CT bone (B) and soft-tissue (C) window images show lytic
punched out lesion arising from frontal sinus (arrows), with
associated large soft-tissue mass.
|
|

View larger version (97K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7C —8-year-old boy with rapidly progressive frontal swelling.
Axial CT bone (B) and soft-tissue (C) window images show lytic
punched out lesion arising from frontal sinus (arrows), with
associated large soft-tissue mass.
|
|
The most common location of maxillofacial involvement of LCH in our series
and reported in the literature is the mandible. The mandible is the second
most common location of LCH involvement overall, the skull being the most
common. Of the 100 patients in this series, 15 had mandible lesions and one of
those was bilateral involvement. Mandible lesions tend to destroy alveolar
bone, which produces the radiologic appearance of "floating teeth"
[3] (Figs.
8A and
8B). The maxilla and/or
maxillary sinus was affected in 8% of patients in the series. In particular,
the hard palate was involved in 3% of the patients in our series
(Fig. 9). Gingival bleeding or
swelling may also be a presenting manifestation of LCH involvement of the hard
palate.
Once thought of as a rare occurrence, orbital involvement in LCH has
increased in frequency in the literature over the past 10 years
[13]. Patients typically
present with proptosis and periorbital edema. The reported incidence of
orbital involvement is 12–20%
[14,
15]. In our series, 11% of
patients had orbital involvement. Characteristically found on CT, a
destructive lesion usually involves the lateral wall of the orbit. A large
soft-tissue component extends into the extraconal space, ocular adnexa, and
infratemporal fossa. The greater wing of the sphenoid bone is typically
eroded, with epidural extension into the middle cranial fossa
[14] (Figs.
10A,
10B,
10C, and
10D). The lateral rectus
muscle is often inseparable from the mass. Previous reports have described
intraocular involvement and brain parenchyma, but these are rare findings.
Orbital masses are usually extraconal and are thought to be of bone origin
[14–17].
The boundaries of the lesion are best delineated on MRI, specifically
T1-weighted sequences with gadolinium. The orbital lesions are typically
isointense on T1, T2, and proton density sequences and enhance avidly after
contrast administration
[18–20].

View larger version (90K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 10A —3-year-old boy who presented with periorbital swelling and
proptosis. Axial CT soft-tissue (A) and bone (B) images show
large mass eroding lateral wall of left orbit and greater wing of sphenoid
bone (arrows).
|
|

View larger version (98K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 10B —3-year-old boy who presented with periorbital swelling and
proptosis. Axial CT soft-tissue (A) and bone (B) images show
large mass eroding lateral wall of left orbit and greater wing of sphenoid
bone (arrows).
|
|

View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 10C —3-year-old boy who presented with periorbital swelling and
proptosis. Coronal T1-weighted MR images, without and with gadolinium
enhancement better delineate borders of this lesion (arrows), located
in lateral orbital wall.
|
|

View larger version (120K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 10D —3-year-old boy who presented with periorbital swelling and
proptosis. Coronal T1-weighted MR images, without and with gadolinium
enhancement better delineate borders of this lesion (arrows), located
in lateral orbital wall.
|
|
CNS Manifestations
LCH commonly affects the CNS; however, rarely is this the only site. The
most common CNS locations involved are the hypothalamic–pituitary axis
and cerebellum [18,
21,
22]. Diabetes insipidus is the
most common endocrine manifestation of LCH. Eleven patients in our series
(11%) had diabetes insipidus. Nine of the 11 patients also had skeletal
involvement. Diabetes insipidus is more commonly observed in association with
multisystem disease, especially in those patients with skull and orbital
involvement [18,
23].
MRI findings in central diabetes insipidus are characterized by lack of
high signal intensity of the posterior pituitary on T1-weighted images, which
is often associated with enhancement and thickening of the pituitary stalk of
greater than 3 mm [4,
24] (Figs.
11A and
11B). However, the posterior
pituitary bright spot frequently persists in patients with diabetes insipidus;
therefore it is not a very reliable characteristic
[25].

View larger version (101K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 11A —16-year-old boy with central diabetes insipidus. Sagittal
T1-weighted image shows thickened pituitary stalk (arrow), indicating
infiltration of infundibulum by Langerhans cell histiocytosis. Note absent
normal posterior pituitary bright spot, common finding in Langerhans cell
histiocytosis patients with diabetes insipidus.
|
|
Neurodegenerative changes are the second most frequent pattern, although
still considered rare, affecting about 1–3% of LCH patients
[4,
26,
27]. The findings compose
mostly bilateral symmetric lesions in the cerebellum and basal ganglia of
variable signal quality on MRI, depending on site and stage of the lesion.
Less frequently, lesions in the extraaxial spaces—the meninges, pineal
gland, and choroid plexus—are observed
[4,
28]. Of 100 patients reviewed
in this series, only 37 patients underwent MRI of the brain. Two (2%) of the
patients had intraparenchymal lesions, both of which were located in temporal
lobes. Two (2%) of the patients showed evidence of cerebral atrophy (Figs.
2A,
2B, and
2C). One patient had mesial
temporal sclerosis, which may have been incidental, and 3% of the patients had
extraaxial lesions. No patients in this series, who underwent MRI of the
brain, showed any evidence of disease in the cerebellum, basal ganglia,
choroid plexus, or pineal gland.
Discussion
In this retrospective review of 100 patients, we described the wide
spectrum of craniofacial and intracranial manifestations of LCH
(Table 1). In our study
population, females and males were equally affected, with approximately a 1:1
ratio. Many studies have stated a male preponderance, citing ratios of between
1.6 and 2.0 to 1
[29–34].
The average age of patients in this series was 4 years and ranged between 4
months and 24 years.
Craniofacial involvement with osseous lesions in the bones of the orbits
and the calvaria has long been recognized as a classic presentation of LCH
[4,
35–37].
Head and neck manifestations of LCH are frequent, with reported frequencies
varying from 50–80% [4,
38,
39]. In our series, 54% of
patients had craniofacial osseous involvement, which included the calvaria,
skull base, temporal, and maxillofacial bones. Calvarial lesions, which are
common, were seen in 45% of patients in this series. These lesions typically
have sharp borders with unequal involvement of the inner and outer tables,
resulting in a characteristic beveled-edge appearance seen on radiographs and
CT scans. These calvarial lesions may or may not have an associated
soft-tissue mass or dural invasion, both of which are better evaluated on MRI.
Classically, these patients present with a tender, palpable scalp soft-tissue
mass.
The clinical manifestations of LCH are widely varied and are entirely
dependent on the particular location of the craniofacial bones involved. For
example, LCH of the temporal bone may manifest as mastoid swelling, deafness,
vertigo, middle ear polyps, otorrhea resistant to medical treatment, and
erosion of the posterior bony external auditory canal
[40]. Delayed diagnoses are
frequent because otological findings are similar to other conditions such as
acute mastoiditis, recurrent chronic otitis media, cholesteatoma, or external
otitis [10,
41].
The characteristic radiologic finding of temporal bone involvement includes
destructive, lytic (punched out) bone lesions involving the mastoids. The
radiologic differential diagnosis includes mastoiditis, rhabdomyosarcoma, and
metastasis [39]. The temporal
or mastoid bone was involved in 13% of patients in our series and in 48% of
those patients with skull base involvement. Reported frequencies of temporal
bone in volvement vary from 15% to 60%
[29,
34,
41,
42–45].
Other less commonly affected areas in the skull base described in this
review are the clivus and jugular foramen. LCH involvement of the clivus has
rarely been reported in the literature and was seen in two patients in this
series [11,
46,
47]. Apart from LCH, the
differential diagnosis of a clival mass in children includes metastatic
disease from neuroblastoma, leukemic deposits, lymphoma, osteomyelitis,
tuberculous or fungal granuloma, chordoma and chondrosarcoma, local extension
from nasopharyngeal carcinoma, or pituitary tumor
[47]. The jugular foramen is
another location rarely involved by LCH. The more common lesions found in the
jugular foramen include paraganglioma, schwannoma, meningioma, and metastasis
[48]. However, in a child with
a skull base lesion, LCH must be included in the differential diagnosis.
Facial swelling is a common clinical problem in the pediatric population.
The origins of a facial mass or swelling can vary from congenital causes to
acquired conditions such as infection and benign or malignant conditions in
soft-tissue or bone. LCH must be considered in the differential diagnosis for
rapidly progressive facial swelling, especially when associated with cranial
nerve deficits [12].
Patients with LCH and bone involvement often have adjacent soft-tissue
involvement. The overall reported incidence of orbital involvement of LCH is
between 12% and 20% [14,
15]. Eleven (11%) patients in
our series had orbital findings. Patients typically present with proptosis,
facial swelling, or periorbital edema. In patients with primary orbital
involvement, other lesions such as metastatic neuroblastoma, osteomyelitis,
Ewing's sarcoma, chloroma, lymphoma, and rhabdomyosarcoma must be excluded
[14]. Both LCH and metastatic
neuroblastoma characteristically involve the posterolateral part of the orbit,
where the frontal bone and greater wing of the sphenoid meet
[12].
The appearance of floating teeth in the mandible or maxilla should also
suggest the diagnosis of LCH, especially when seen in conjunction with
multiple skull lesions in a pediatric patient. The floating-teeth appearance
can also occur in patients with metastatic neuroblastoma, malignant lymphoma,
and familial dysgammaglobulinemia
[3,
49]. Usually affecting 10% of
LCH patients, the mandible is the second most common bone involved in LCH,
with the skull being the most common
[29,
32]. These patients usually
present with gingival bleeding/swelling or facial swelling. Typically
associated with mandible or maxilla lesions, the gingival tissues are affected
frequently in patients with LCH, with reported frequencies up to 20%
[2,
35].
CNS involvement in LCH is common, and has been reported in 16% of patients
[13,
50]. The most common
intracranial site of involvement is the hypothalamic-pituitary axis
[13,
51]. Diabetes insipidus is the
most common endocrine manifestation of LCH and is attributable to decreased
secretion of antidiuretic hormone
[18]. Growth hormone
deficiency (GHD) is the most frequent anterior pituitary hormone deficiency
among patients with LCH and pituitary dysfunction. GHD is usually diagnosed
years after posterior pituitary deficiency and is responsible for growth
retardation. Described initially as a rare complication, GHD is now estimated
to affect up to 42% of LCH patients with diabetes insipidus
[52–56].
Eleven patients in our series (11%) had diabetes insipidus, which is
consistent with recent literature, which varies from 10% to 20%
[5,
29,
33,
34].
Other intracranial CNS changes have been reported recently in the
literature with increasing frequency. According to Prayer et al.
[4], in a series of 163
patients, neurodegenerative gray-matter changes in the cerebellum occurred in
40% of patients and basal ganglia in 26% of patients. Intraaxial, white-matter
parenchymal changes resulted in a leukoencephalopathy-like pattern in 36%.
Meningeal lesions were found in 29%, and choroid plexus involvement was seen
in 6%. These intracranial CNS changes were rarely seen in our series of 100
patients, although only 37 patients underwent MRI of the brain during their
clinical course.
In conclusion, LCH can be a diagnostic dilemma for pediatricians and
radiologists. Although most commonly presenting as eosinophilic granuloma or
solitary bone lesion, the clinical presentation varies greatly depending on
the precise location of involvement. Common clinical presentations include
scalp or facial swelling, seizures, hearing loss, recurrent otitis media,
gingival bleeding, proptosis, diabetes insipidus, and cranial nerve palsies.
Typically found on imaging as an aggressive intracranial or craniofacial
lesion, LCH must be included in the differential diagnosis of malignant
processes such as metastatic neuroblastoma or rhabdomyosarcoma and benign
processes such as osteomyelitis.
References
- Park SH, Park J, Hwang JH, Hwang SK, Hamm IS, Park YM. Eosinophilic
granuloma of the skull: a retrospective analysis. Pediatr
Neurosurg 2007; 43:97
-101[CrossRef][Medline]
- Hoover KB, Rosenthal DI, Mankin H. Langerhans cell histiocytosis.
Skeletal Radiol 2007;36
: 95-104[CrossRef][Medline]
- Stull MA, Kransdorf MJ, Devaney KO. Langerhans cell histiocytosis
of bone. RadioGraphics 1992;12
: 801-823[Abstract]
- Prayer D, Grois N, Prosch H, Gadner H, Barkovich AJ. MR imaging
presentation of intracranial disease associated with Langerhans cell
histiocytosis. Am J Neuroradiol 2004;25
: 880-891[Abstract/Free Full Text]
- Meyer JS, Harty MP, Mahboubi S, et al. Langerhans cell
histiocytosis: presentation and evolution of radiologic findings with clinical
correlation. RadioGraphics 1995;15
: 1135-1146[Abstract]
- Arana E, Martí-Bonmati L. CT and MR imaging of focal
calvarial lesions. AJR 1999;172
: 1683-1688[Free Full Text]
- Krasnokutsky MV. The button sequestrum sign.
Radiology 2005;236
: 1026-1027[Free Full Text]
- Hadjigeorgi C, Parpounas C, Zarmakoupis P, Lafoyianni S.
Eosinophilic granuloma of the temporal bone: radiological approach in the
pediatric patient. Pediatr Radiol 1990;20
: 546-549[CrossRef][Medline]
- Cunningham MJ, Curtin HD, Jaffe R, Stool SE. Otologic
manifestations of Langerhans' cell histiocytosis. Arch Otolaryngol
Head Neck Surg 1989; 115:807
-813[Abstract/Free Full Text]
- Marioni G, De Filippis C, Stramare R, Carli M, Staffieri A.
Langerhans' cell histiocytosis: temporal bone involvement. J
Laryngol Otol 2001; 115:839
-841[Medline]
- Brisman JL, Feldstein NA, Tarbell NJ, et al. Eosinophilic granuloma
of the clivus: case report, follow-up of two previously reported cases, and
review of the literature on cranial base eosinophilic granuloma.
Neurosurgery 1997;41
: 273-278[CrossRef][Medline]
- Khanna G, Sato Y, Smith RJ, Bauman NM, Nerad J. Causes of facial
swelling in pediatric patients: correlation of clinical and radiologic
findings. RadioGraphics 2006;26
: 157-171[Abstract/Free Full Text]
- Kramer TR, Noecker RJ, Miller JM, Clark LC. Langerhans cell
histiocytosis with orbital involvement. Am J
Ophthalmol 1997; 124:814
-824[Medline]
- Erly WK, Carmody RF, Dryden RM. Orbital histiocytosis X.
Am J Neuroradiol 1995;16
: 1258-1261[Abstract]
- Moore AT, Pritchard J, Taylor DS. Histiocytosis X: an
ophthalmological review. Br J Ophthalmol1985; 69:7
-14[Abstract/Free Full Text]
- Banna M, Olutola PS. Orbital histiocytosis on computed tomography.
J Comput Tomogr 1983;7
: 167-170[CrossRef][Medline]
- Caresio JF, McMillan JH, Batnitzky S. Coexistent intra- and
extracranial mass lesions: an unusual manifestation of histiocytosis X.
Am J Neuroradiol 1991;12
: 82[Medline]
- Stromberg JS, Wang AM, Huang TE, Vicini FA, Nowak PA. Langerhans
cell histiocytosis involving the sphenoid sinus and superior orbital fissure.
Am J Neuroradiol 1995;16
: 964-967[Abstract]
- O'Sullivan RM, Sheehan M, Poskitt KJ, Graeb DA, Chu AC, Joplin GF.
Langerhans cell histiocytosis of the hypothalamus and optic chiasm: CT and MR
studies. J Comput Assist Tomogr 1991;15
: 52-55[Medline]
- Reid WM, Deveikis JP, Schellinger D, Patronas NJ, Stull MA.
Neuroradiology case of the day: hypothalamic histiocytosis X.
AJR 1990; 154:1338
-1340[Medline]
- Favara BE, Jaffe R. Pathology of Langerhans cell histiocytosis.
Hematol Oncol Clin North Am 1987;1
: 75-97[Medline]
- Burn DJ, Watson JDG, Roddie M, Chu AC, Legg NJ, Frackowiak RSJ.
Langerhans' cell histiocytosis and the nervous system. J
Neurol 1992; 239:345
-350[CrossRef][Medline]
- Dunger DB, Broadbent V, Yeoman E, et al. The frequency and natural
history of diabetes insipidus in children with Langerhans cell histiocytosis.
N Engl J Med 1989;321
: 1157-1162[Abstract]
- Maghnie M, Arico M, Villa A, Genovese E, Beluffi G, Severi F. MR of
the hypothalamic-pituitary axis in Langerhans cell histiocytosis.
Am J Neuroradiol 1992;13
: 1365-1371[Abstract]
- Maghnie M, Genovese E, Bernasconi S, Binda S, Arico M. Persistent
high MR signal of the posterior pituitary gland in central diabetes insipidus.
Am J Neuroradiol 1997;18
: 1749-1752[Abstract]
- [No authors listed]. A multicentre retrospective survey of LCH: 348
cases between 1983 and 1993—The French LCH Study Group. Arch
Dis Child 1996; 75:17
-24[Abstract/Free Full Text]
- Grois NG, Favara BE, Mostbeck GH, Prayer D. Central nervous system
disease in Langerhans cell histiocytosis. Hematol Oncol Clin North
Am 1998; 12:287
-305[CrossRef][Medline]
- Grois NG, Prayer D, Prosch H, Lassmann H; CNS LCH Co-operative
Group. Neuropathology in CNS disease in Langerhans cell histiocytosis.
Brain 2005;128
(Pt. 4):829
-838[Abstract/Free Full Text]
- Cochrane LA, Prince M, Clarke K. Langerhans' cell histiocytosis in
the paediatric population: presentation and treatment of head and neck
manifestations. J Otolaryngol 2003;32
: 33-37[CrossRef][Medline]
- Malpas JS. Langerhans cell histiocytosis in adults.
Hematol Oncol Clin North Am 1998;12
: 259-268[CrossRef][Medline]
- Quraishi MS, Blayney AW, Walker D, Breatnach FB, Bradley PJ.
Langerhans cell histiocytosis: head and neck manifestations in children.
Head Neck 1995; 3:226
-231
- Irving RM, Broadbent V, Jones NS. Langerhans' cell histiocytosis in
childhood: management of head and neck manifestations.
Laryngoscope 1994;104
: 64-70[Medline]
- Nicholson SH, Egeler M, Nesbit ME. The epidemiology of Langerhans
cell histiocytosis. Hematol Oncol Clin North Am1998; 12:379
-384[CrossRef][Medline]
- al-Ammar AY, Tewfik TL, Bond M, Schloss MD. Langerhans' cell
histiocytosis: paediatric head and neck study.
Otolaryngol 1999;28
: 266-272
- Hand A. Defects of membranous bones, exophthalmus and polyuria in
childhood: is it dyspituitarism? Am J Med Sci1921; 162:509
-515
- Holbach LM, Colombo F, Heckmann JG, Strauss C, Döbig C.
Langerhans-cell histiocytosis of the orbit; diagnosis, treatment and outcome
in three patients—children and adults [in German]. Klin
MonatsblAugenheilkd 2000;217
: 370-373
- Char DH, Ablin A, Beckstead J. Histiocytic disorders of the orbit.
Ann Ophthalmol 1984;16
: 867-873[Medline]
- Dinardo LJ, Wettmore RF. Head and neck manifestations of
histiocytosis X in children. Laryngoscope1989; 99:721
-724[Medline]
- Fernández-Latorre F, Menor-Serrano F, Alonso-Charterina S,
Arenas-Jiménez J. Langerhans' cell histiocytosis of the temporal bone
in pediatric patients: imaging and follow-up. AJR2000; 174:217
-221[Abstract/Free Full Text]
- McCaffrey TV, McDonald TJ. Histiocytosis X of the ear and temporal
bone: review of 22 cases. Laryngoscope1979; 89:1735
-1742[Medline]
- Appling D, Jenkins HA, Patton GA. Eosinophilic granuloma in the
temporal bone and skull. Otolaryngol Head Neck Surg1983; 91:358
-365[Medline]
- Sellari-Franceschini S, Forli F, Pierini S, Favre C, Berrettini S,
Macchia PA. Langerhans' cells histiocytosis. Int J Pediatr
Otorhinolaryngol 1999; 48:83
-87[CrossRef][Medline]
- Tos M. A survey of Hand-Schüller-Christian's disease in
otolaryngology. Acta Otolaryngol 1966;62
: 217-228[CrossRef][Medline]
- Peuchot M, Eftekhari F, Van Tassel P, Cangir A. Computed tomography
in histiocytosis X of the temporal bone. J Comp Tomogr1988; 12:9
-12[CrossRef]
- Cunningham MJ, Curtin HD, Jaffe R, Stool SE. Otologic
manifestations of Langerhans' cell histiocytosis. Arch Otolaryngol
Head Neck Surg 1989; 115:807
-813[Abstract/Free Full Text]
- Hurley M, O'Meara A, Fagarty E, Hayes R. Langerhans cell
histiocytosis of the clivus: case report and literature review.
Pediatr Radiol 2004;34
: 267-270[CrossRef][Medline]
- Krishna H, Behari S, Pal L, et al. Solitary Langerhans cell
histiocytosis of the clivus and sphenoid sinus with parasellar and petrous
extensions: case report and review of literature. Surg
Neur 2004; 62:447
-454[CrossRef]
- Shimono T, Akai F, Yamamoto A, et al. Different signal intensities
between intra-and extracranial components in jugular foramen meningioma: an
enigma. Am J Neuroradiol 2005;26
: 1122-1127[Abstract/Free Full Text]
- Wilner D. Radiology of bone tumors and allied
disorders. Philadelphia, PA: Saunders, 1982:1330
-1435
- Berry DH, Becton DL. Natural history of histiocytosis-X.
Hematol Oncol Clin North Am 1987;1
: 23-34[Medline]
- Kepes JJ, Kepes M. Predominantly cerebral forms of histiocytosis-X.
Acta Neuropathol 1969;14
: 77-98[CrossRef][Medline]
- Donadieu J, Rolon MA, Pion I, et al.; French LCH Study Group.
Incidence of growth hormone deficiency in pediatric-onset Langerhans cell
histiocytosis: efficacy and safety of growth hormone treatment. J
Clin Endocrinol Metab 2004;89
: 604-609[Abstract/Free Full Text]
- Braunstein GD, Kohler PO. Pituitary function in
Hand-Schüller-Christian disease. N Engl J Med1972; 286:1225
-1229[Medline]
- Braunstein GD, Raiti S, Hansen JW, Kohler PO. Response of growth
retarded patients with Hand-Schüller-Christian disease to growth hormone
therapy. N Engl J Med 1975;292
: 332-333[Medline]
- Braunstein GD, Kohler PO. Endocrine manifestations of
histiocytosis. Am J Pediatr Hematol Oncol1981; 3:67
-75[Medline]
- Dean HJ, Bishop A, Winter JS. Growth hormone deficiency in patients
with histocytosis X. J Pediatr 1986;109
: 615-618[CrossRef][Medline]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?